Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?

• 作者Philippe Aftimos; Ahmad Awada
• 卷第28卷
• 期第11期
• 印刷ISSN0741-238X
• 电子ISSN1865-8652
• 文件大小610.05KB
• 发表时间2011-11
• DOI10.1007/s12325-011-0070-9
• 页码973-985